Novel insights into actions of bisphosphonates on bone: Differences in interactions with hydroxyapatite

Nancollas, G.H., Tang, R., Phipps, R.J., Henneman, Z., Gulde, S., Wu, W., Mangood, A., Russell, R.G.G., Ebetino, F.H.·2006·Bone
DOI 10.1016/j.bone.2005.05.003

Cited by (865)

Items 501–600 of 865

  1. A narrative review of the pharmaceutical management of osteoporosis
    Devon Patel, Courtney Gorrell, Jordan Norris, Jiayong Liu · 2023 · Annals of Joint
  2. Osteoporosis treatment: why ibandronic acid?
    Maurizio Rossini, Giovanni Orsolini, Silvano Adami, Vidya Kunnathully, Davide Gatti · 2013 · Expert Opinion on Pharmacotherapy
  3. Long-Term Bone Scintigraphy Results After Intravenous Zoledronate in Paget’s Disease of Bone
    Ian R. Reid, Katherine Maslowski · 2017 · Calcified Tissue International
  4. Preparation of calcium phosphate nanoparticles hybridized with europium(III) complex for novel luminescent organic-inorganic systems
    Takuya Kataoka, Kenji Shinozaki, Shigeaki Abe, Motohiro Tagaya · 2018 · Journal of Physics and Chemistry of Solids
  5. New insights on physico-chemical investigation of bisphosphonate adsorption isotherm into apatite substrate using statistical physics treatment
    Aljawhara H. Almuqrin, Sarra Wjihi, Fatma Aouaini, Abdelmottaleb Ben Lamine · 2020 · Journal of Molecular Liquids
  6. Formation of 1-Hydroxymethylene-1,1-bisphosphinates through the Addition of a Silylated Phosphonite on Various Trivalent Derivatives
    Jade Dussart‐Gautheret, Julia Deschamp, Maëlle Monteil, Olivier Gager, Thibaut Legigan, Evelyne Migianu‐Griffoni, Marc Lecouvey · 2020 · The Journal of Organic Chemistry
  7. Isolation of calcium phosphate crystals from complex biological fluids using bisphosphonate-modified superparamagnetic beads
    Aarón Hernández-Santana, Alexander Yavorskyy, Adedayo Olinyole, Géraldine McCarthy, Gillian P. McMahon · 2008 · Chemical Communications
  8. Efficacy of zoledronic acid treatment in Paget disease of bone
    Emine Kartal Baykan, Füsun Saygılı, Mehmet Erdoğan, Şevki Çetinkalp, Gökhan Özgen, C. Yilmaz · 2014 · Osteoporosis International
  9. Influence of pH on osteoclasts treated with zoledronate and alendronate
    Francisco Javier Manzano‐Moreno, Javier Ramos‐Torrecillas, Elvira De Luna‐Bertos, Rebeca Illescas Montes, Timothy R. Arnett, Concepción Ruíz, Olga García‐Martínez · 2018 · Clinical Oral Investigations
  10. Local administration of zoledronic acid prevents traumatic osteonecrosis of the femoral head in rat model
    Jun Zhao, Yue Tian, Shibi Lu, Haoye Meng, Qiuxia Lin, Haiyang Ma, Guangbo Liu, Li Huo, Qiang Lu, Aiyuan Wang et al. · 2021 · Journal of Orthopaedic Translation
  11. Treatment of glucocorticoid-induced osteoporosis
    Gherardo Mazziotti, Andrea Giustina, ERNESTO M. CANALIS, John Paul Bilezikian · 2009 · Therapeutic Advances in Musculoskeletal Disease
  12. Osteogenesis Improvement of Gelatin-Based Nanocomposite Scaffold by Loading Zoledronic Acid
    Abdulahy, Sayed Behnam, Esmaeili Bidhendi, Mona, Vaezi, Mohammad Reza, Moosazadeh Moghaddam, Mehrdad · 2022 · Frontiers in Bioengineering and Biotechnology
  13. Poly(vinyl alcohol)/hydroxyapatite Monolithic In-Needle Extraction (MINE) device: Preparation and examination of drug affinity
    Monika Zielińska, Michał Czerwiński, Adam Voelkel · 2017 · European Journal of Pharmaceutical Sciences
  14. Adjuvant drug-assisted bone healing: Part III – Further strategies for local and systemic modulation
    Rebecca Rothe, Sabine Schulze, Christin Neuber, Sandra Hauser, Stefan Rammelt, Jens Pietzsch · 2019 · Clinical Hemorheology and Microcirculation
  15. Bisphosphonates as Potential Inhibitors of Calcification in Bioprosthetic Heart Valves (Review)
    T.P. Timchenko · 2022 · Современные технологии в медицине
  16. Zoledronate and osteonecrosis of the jaw in osteoporosis: incidence and risk factors. Analysis of the French Pharmacovigilance Database
    Claire Amigues, Audrey Fresse, Christian Hubert Roux, Sophie Gauthier, Marie-Hélène Vieillard, Milou‐Daniel Drici, Véronique Breuil · 2023 · Joint Bone Spine
  17. The Molecular Mechanisms of Action of Bisphosphonates
    Keith Thompson, Michael J. Rogers · 2007 · Clinical Reviews in Bone and Mineral Metabolism
  18. Tratamiento de la enfermedad ósea de Paget
    L. Lojo, Antonio Torrijos Eslava · 2012 · Reumatología Clínica
  19. Once-monthly oral ibandronate in postmenopausal osteoporosis: Translation and updated review
    Maurizio Rossini, Ombretta Viapiana, Davide Gatti, Silvano Adami · 2009 · Clinical Therapeutics
  20. Calcium Phosphate Surface Tailoring Technologies for Drug Delivering and Tissue Engineering
    2012 · BENTHAM SCIENCE PUBLISHERS eBooks
  21. High-scale yield of nano hydroxyapatite through combination of mechanical activation and chemical dispersion
    Xueling Gao, Chunchu Dai, Weiwei Liu, Yumei Liu, Ru Shen, Xiaotong Zheng, Ke Duan, Jie Weng, Shuxin Qu · 2017 · Journal of Materials Science Materials in Medicine
  22. Metal-organic frameworks for biomedical applications: The case of functional ligands
    Jéssica S. Barbosa, Flávio Figueira, Susana Santos Braga, Filipe A. Almeida Paz · 2020 · Elsevier eBooks
  23. Bone mineral density measurements performed by cone-beam computed tomography in the bisphosphonate-related osteonecrosis-affected jaw
    Philipp Metzler, Wolfgang Zemann, Heinz‐Theo Lübbers, Roman Guggenberger, Anja Lüssi, Joachim Anton Obwegeser, Klaus W. Grätz, Christine Jacobsen · 2012 · Oral Radiology
  24. OSTEOPOROSIS DIAGNOSIS AND TREATMENT
    Márcio Passini Gonçalves de Souza · 2010 · Revista Brasileira de Ortopedia (English Edition)
  25. Mineral and bone disorders in conventional hemodialysis: Challenges and solutions
    Takayuki Hamano · 2018 · Seminars in Dialysis
  26. Bisphosphonates
    Anke J. Roelofs, Frank H. Ebetino, Alfred A. Reszka, R.G.G. Russell, Michael J. Rogers · 2008 · Elsevier eBooks
  27. Paget’s disease of bone: emphasis on treatment with zoledronic acid
    Stergios A. Pοlyzos, Athanasios D. Anastasilakis, Evangelos Terpos · 2009 · Expert Review of Endocrinology & Metabolism
  28. A Series of Imidazolyl-Containing Bisphosphonates with Abundant Hydrogen-Bonding Interactions: Syntheses, Structures, and Bone-Binding Affinity
    Ling Qiu, Jianguo Lin, Liqing Wang, Wen Dan Cheng, Yang Cao, Xuewen Liu, Shineng Luo · 2013 · Australian Journal of Chemistry
  29. A comparative study of zoledronic acid and once weekly Alendronate in the management of acute Charcot arthropathy of foot in patients with diabetes mellitus
    R Bharath, Arun Bal, Shanmuga Sundaram, AG Unnikrishnan, V. P. Praveen, Nisha Bhavani, Vasantha Nair, RV Jayakumar, Harish Kumar · 2013 · Indian Journal of Endocrinology and Metabolism
  30. Functional Analyses of Four CYP1A1 Missense Mutations Present in Patients with Atypical Femoral Fractures
    Nerea Ugartondo, Núria Martínez‐Gil, María Esteve, Natalia García‐Giralt, Neus Roca‐Ayats, Diana Ovejero, Xavier Nogués, Adolfo Díez‐Pérez, Raquel Rabionet, Daniel Grinberg et al. · 2021 · International Journal of Molecular Sciences
  31. Risedronate complexes with Mg2+, Zn2+, Pb2+, and Cu2+: Species thermodynamics and sequestering ability in NaCl(aq) at different ionic strengths and at T = 298.15 K
    Clemente Bretti, Concetta De Stefano, Paola Cardiano, Salvatore Cataldo, Alberto Pettignano, Giuseppe Arena, Carmelo Sgarlata, Giuseppa Ida Grasso, Gabriele Lando, Silvio Sammartano · 2021 · Journal of Molecular Liquids
  32. Effects of Bisphosphonates on Fracture Incidence and Bone Metabolism in Rheumatoid Arthritis Patients in General Practice Taking Long-Term Corticosteroid Therapy
    Kou Katayama, Takeo Matsuno · 2008 · Clinical Drug Investigation
  33. Synthesis of novel polymerizable molecules bearing bisphosphonate
    S. Kachbi Khelfallah, Maëlle Monteil, Julia Deschamp, Olivier Gager, Evelyne Migianu‐Griffoni, Marc Lecouvey · 2015 · Organic & Biomolecular Chemistry
  34. Microfibrous borate bioactive glass dressing sequesters bone-bound bisphosphonate in the presence of simulated body fluid
    Chandrani Pramanik, Wang Tianda, Sushanta Ghoshal, Li‐na Niu, Bradley A. Newcomb, Yaodong Liu, Carolyn M. Primus, Hailan Feng, David Henry Pashley, Satish Kumar et al. · 2015 · Journal of Materials Chemistry B
  35. Management of postmenopausal osteoporosis
    Ian R. Reid, Mark J Bolland · 2026 · Endocrine Reviews
  36. Bisphosphonate-related osteonecrosis of the jaw in non-malignant bone disease
    Peter K. K. Wong, Gelsomina L. Borromeo, John D. Wark · 2013 · Rheumatology International
  37. Direct covalent attachment of Mn( iii ) salophen complex to the hydroxyapatite-encapsulated γ-Fe 2 O 3 nanocrystallites: an efficient magnetic and reusable catalyst for oxidation of alcohols
    Ali Saffar‐Teluri · 2015 · RSC Advances
  38. Bisphosphonate-associated osteonecrosis of the jaw 2 years after teeth extractions: a case report solved with non-invasive treatment.
    Gerardo Gómez Moreno, M C Arribas-Fernández, M Fernández-Guerrero, Ana Boquete‐Castro, Antonio Aguilar‐Salvatierra, J Guardia, Daniele Botticelli, José Luís Calvo‐Guirado · 2014 · PubMed
  39. In vitro incorporation studies of 99mTc–alendronate sodium at different bone cell lines
    Evren Gündoğdu, Derya İlem‐Özdemir, Makbule Aşıkoğlu · 2013 · Journal of Radioanalytical and Nuclear Chemistry
  40. An investigation into nanohybrid states of europium (III) complex with hydroxyapatite nanocrystals
    Takuya Kataoka, Kota Shiba, Motohiro Tagaya · 2018 · Optical Materials
  41. Progress and Current Status in Hajdu-Cheney Syndrome with Focus on Novel Genetic Research
    Natsuko Aida, Tatsukuni Ohno, Toshifumi Azuma · 2022 · International Journal of Molecular Sciences
  42. Low-energy femoral shaft fractures after long-term alendronate therapy: report of seven cases
    Efstathios G. Ballas, Andreas F. Mavrogenis, Eirineos Karamanis, Zinon T. Kokkalis, Evanthia A. Mitsiokapa, Demetrios Koulalis, Dimitrios Stylianos Mastrokalos, Panayiotis J. Papagelopoulos · 2014 · European Journal of Orthopaedic Surgery & Traumatology
  43. Bone-Bound Bisphosphonates Inhibit Proliferation of Breast Cancer Cells
    Young Eun Park, Usha Bava, Jianming Lin, Jillian Cornish, Dorit Naot, Ian R. Reid · 2019 · Calcified Tissue International
  44. Bisphosphonates: Mechanisms of Action and Role in Osteoporosis Therapy
    Arthur C. Santora, Anupa Sharma · 2020 · Contemporary Endocrinology
  45. Determination of bisphosphonates anti-resorptive properties based on three forms of ceramic materials: Sorption and release process evaluation
    Monika Zielińska, Ewa Chmielewska, Tomasz Buchwald, Adam Voelkel, Pawel K. Kafarski · 2020 · Journal of Pharmaceutical Analysis
  46. Mineral and organic matrix composition at bone forming surfaces in postmenopausal women with osteoporosis treated with either teriparatide or zoledronic acid
    Eleftherios P. Paschalis, David W. Dempster, Sonja Gamsjaeger, Stamatia G. Rokidi, Norbert Hassler, Wolfgang Brozek, Faye Chan-Diehl, Klaus Klaushofer, Kathleen A. Taylor · 2021 · Bone
  47. Calcium Phosphate Ceramics as Bone Drug-Combined Devices
    Élise Verron, Jean‐Michel Bouler · 2010 · Key engineering materials
  48. Characteristics and mechanical properties of acrylolpamidronate‐treated strontium containing bioactive bone cement
    Z. Y. Li, Cheng Yang, William W. Lu, Bing Xu, W. M. Lam, Guoxin Ni, Sunny Akogwu Abbah, Fan Yang, Kmc Cheung, Keith D. K. Luk · 2007 · Journal of Biomedical Materials Research Part B Applied Biomaterials
  49. Bisfosfonatbehandling av osteoporose og andre skjelettsykdommer
    Unni Syversen, Johan Halse · 2011 · Tidsskrift for Den norske legeforening
  50. Biomaterial Thin Films by Soft Pulsed Laser Technologies for Biomedical Applications
    Ion Nicolae Mihailescu, Adriana Bigi, Enikö György, Carmen Ristoscu, Félix Sima, Ebru Toksoy Öner · 2014 · Springer series in materials science
  51. Patient satisfaction and efficacy of switching from weekly bisphosphonates to monthly minodronate for treatment and prevention of glucocorticoid-induced osteoporosis in Japanese patients with systemic rheumatic diseases: a randomized, clinical trial
    Shin‐ya Tamechika, Kaneshige Sasaki, Yoshihito Hayami, Shin‐ichiro Ohmura, Shinji Maeda, Shiho Iwagaitsu, Taio Naniwa · 2018 · Archives of Osteoporosis
  52. Bone metastases in the era of targeted treatments: insights from molecular biology
    Jonatan Dewulf, Christel Vangestel, Yannick Verhoeven, Peter A. van Dam, Filipe Elvas, Tim VAN DEN WYNGAERT, Philippe Clézardin · 2019 · The Quarterly Journal of Nuclear Medicine and Molecular Imaging
  53. Approach to the management of β thalassemia major associated osteoporosis - A long-standing relationship revisited.
    Maria P. Yavropoulou, Athanasios D. Anastasilakis, Ploutarchos Tzoulis, Symeon Tournis, Efthimia Rigatou, Eva N. Kassi, Antonis Kattamis, Polyzois Makras · 2022 · Acta bio-medica dell'Ateneo parmense/Acta biomedica
  54. Effect of Sequential Treatment with Bisphosphonates After Teriparatide in Ovariectomized Rats: A Direct Comparison Between Risedronate and Alendronate
    Tetsuo Yano, Mei Yamada, Daisuke Inoue · 2017 · Calcified Tissue International
  55. Skeletal accumulation of fluorescently tagged zoledronate is higher in animals with early stage chronic kidney disease
    Elizabeth A. Swallow, Mohammad W. Aref, Neal X. Chen, Innocent Byiringiro, Max A. Hammond, Brian Paul McCarthy, Paul R. Territo, Malgorzata Maria Kamocka, Seth Winfree, Kenneth W. Dunn et al. · 2018 · Osteoporosis International
  56. Nanoscale Imaging and Analysis of Bone Pathologies
    Victoria Garcia-Giner, Zexiang Han, Finn Giuliani, Alexandra E. Porter · 2021 · Applied Sciences
  57. Is the Use of Bisphosphonates Putting Horses at Risk? An Osteoclast Perspective
    Fernando B. Vergara‐Hernandez, Brian D. Nielsen, Aimée C. Colbath · 2022 · Animals
  58. Microfluidic synthesis of zoledronic acid loaded chitosan nanoparticles used for osteogenic differentiation of mesenchymal cells
    Maryam Khayati, Hamidreza Kheiri Manjili, Masoud Soleimani, Simzar Hosseinzadeh, Mohammad Akrami, Ismaeil Haririan, Seyed Hossein Ahmadi Tafti · 2022 · International Journal of Biological Macromolecules
  59. Alendronate for Effective Treatment of Male Osteoporosis: An Insight
    Hanan Al Lawati, Sara Al Busaidi, Thuraiya Al Rawahia, Abdullah Al Lawati, Ahmed Kifah, Srijit Das · 2024 · Current Pharmaceutical Design
  60. Dextran formation on hydroxyapatite by immobilized dextransucrase to control protein adsorption
    Hidetaka Kawakita, Akihito Gyotoku, Hirokazu Seto, Keisuke Ohto, Hiroyuki Harada, Katsutoshi Inoue · 2008 · Carbohydrate Polymers
  61. Novel fluorescent risedronates: Synthesis, photodynamic inactivation and imaging of Bacillus subtilis
    Lisheng Zhou, Ke‐Wu Yang, Lei Feng, Jian-Min Xiao, Chengcheng Liu, Yilin Zhang, Michael W. Crowder · 2012 · Bioorganic & Medicinal Chemistry Letters
  62. Etidronate: What is its place in treatment of primary osteoporosis and other demineralizing diseases today?
    Adriana Gabriela Ioachimescu, Angelo A. Licata · 2007 · Current Osteoporosis Reports
  63. Neonatal transient hypophosphatemic hypercalciuric rickets in dizygous twins: A role for maternal alendronate therapy before pregnancy or antireflux medications?
    M. Gerin, G. Jambon, Anne Fouque-Aubert, C. Raybaud, Pierre Cochat, Olivier Claris, Justine Bacchetta · 2016 · Archives de Pédiatrie
  64. Atypical femoral fracture in a beta-thalassemia major patient with previous bisphosphonate use: case report and a review of the literature.
    Kalliopi I. Lampropoulou-Adamidou, Symeon Tournis, Ioannis Κ. Triantafyllopoulos · 2016 · PubMed Central
  65. Theoretical study of the deposition and adsorption of bisphosphonates on the 001 hydroxyapatite surface: Implications in the pathological crystallization inhibition and the bone antiresorptive action
    David Fernández, Joaquín Ortega‐Castro, Juan Frau · 2016 · Applied Surface Science
  66. Long-Term Effects of Intravenous Ibandronate in Paget’s Disease of Bone
    Ian R. Reid, Diana J. Wattie, Greg D. Gamble, Ramanamma Kalluru, Tim Cundy · 2016 · Calcified Tissue International
  67. Thermodynamics (Solubility and Protonation Constants) of Risedronic Acid in Different Media and Temperatures (283.15–318.15 K)
    Clemente Bretti, Concetta De Stefano, Gabriele Lando, Kavosh Majlesi, Silvio Sammartano · 2017 · Journal of Solution Chemistry
  68. Prescrition Drug Therapies
    Mary Beth O’Connell · 2006 · Journal of Managed Care Pharmacy
  69. Clodronic Acid in the Treatment of Postmenopausal Osteoporosis
    Refik Tanakol, Sema Yarman, Taner Bayraktaroğlu, Harika Boztepe, Faruk Alag l · 2007 · Clinical Drug Investigation
  70. Oral Ibandronate in Postmenopausal Osteoporotic Women Alters Micromechanical Properties Independently of Changes in Mineralization
    Yohann Bala, Joseph D. Kohles, Robert R. Recker, Georges Boivin · 2012 · Calcified Tissue International
  71. Development of clinical utility of zoledronic acid and patient considerations in the treatment of osteoporosis
    Johann Diederich Ringe · 2010 · Patient Preference and Adherence
  72. Treatment of Paget's Disease of Bone
    L. Lojo, Antonio Torrijos Eslava · 2012 · Reumatología Clínica (English Edition)
  73. Bisphosphonate Mechanisms of Action
    Alfred A. Reszka · 2009 · Humana Press eBooks
  74. Preparation and evaluation of rhenium-188-pamidronate as a palliative treatment in bone metastasis
    Mostafa Erfani, Nasim Rahmani, Alireza Doroudi, Mohammad Shafiei · 2017 · Nuclear Medicine and Biology
  75. Open Issues in Anorexia Nervosa
    Vincenzina Bruni, MARIA FRANCESCA FILICETTI, Valentina Pontello · 2006 · Annals of the New York Academy of Sciences
  76. Zoledronic acid in the treatment of Paget’s disease and other benign bone disorders
    Johann Diederich Ringe · 2006 · Expert Review of Endocrinology & Metabolism
  77. Clinical Pharmacology of Bisphosphonates
    Partha S. Sinha, Harold N. Rosen · 2019 · Elsevier eBooks
  78. Current and emerging bone resorption inhibitors for the treatment of osteoporosis
    Apostolos I. Gogakos, Athanasios D. Anastasilakis · 2025 · Expert Opinion on Pharmacotherapy
  79. AMP1-1 alleviates bone loss in weightless rats by reducing peripheral 5-HT content via the microbiota-gut-bone axis
    Fan Yang, Qiuxin Yan, Yunhao Wang, Qiao Li, Jinpeng Wang, Xiangyin Zeng, Yaning Pi, Manrui Zhang, Lijun Wei · 2025 · Phytomedicine
  80. Solid-state NMR spectroscopy for unraveling structure and dynamics in biomaterials
    Rahul Yadav, Bijaylaxmi Patra, Ratan Rai, Neeraj Sinha, Chandan Singh · 2025 · Solid State Nuclear Magnetic Resonance
  81. Bisphosphonates Preserve Bone Mineral Density and Suppress Bone Turnover Markers in Early Menopausal Women: A Systematic Review and Meta‐Analysis of Randomized Trials
    Aria Ahadzadeh Ardebili, Timothy Yu-Chi Fu, Nicole Dunnewold, Fariba Aghajafari, Emma O. Billington · 2023 · JBMR Plus
  82. Comparative evaluation of the clinical and radiographic efficacy of 0.05% zoledronate gel as local drug delivery system in treating intrabony defects in stage III grade B periodontitis patients with and without type‐2 diabetes mellitus—A randomized split‐mouth clinical trial
    Subash Chandra Raj, Asit Kumar Mishra, Devapratim Mohanty, Neelima Katti, Snigdha Pattnaik, Laxmikanta Patra, Abinash Pattanaik · 2023 · Clinical Advances in Periodontics
  83. Modified‐Hydroxyapatite‐Chitosan Hybrid Composite Interfacial Coating on 3D Polymeric Scaffolds for Bone Tissue Engineering
    Deepak Poddar, Ankita Singh, Pranshu Rao, Sujata Mohanty, Purnima Jain · 2023 · Macromolecular Bioscience
  84. Methodological guidance for the use of real-world data to measure exposure and utilization patterns of osteoporosis medications
    Kaleen N. Hayes, Suzanne M. Cadarette, Andrea Michelle Burden · 2023 · Bone Reports
  85. In-vivo near-infrared optical imaging of growing osteosarcoma cell lesions xenografted in mice: dual-channel quantitative evaluation of volume and mineralization
    Hitoshi Nakayama, Tomoyuki Kawase, Kazuhiro Okuda, Larry F. Wolff, Hiromasa Yoshie · 2011 · Acta Radiologica
  86. Efficacy of ibandronate: a long term confirmation.
    Ombretta Di Munno, Andrea Delle Sedie · 2010 · PubMed Central
  87. The kinetic study of the thermally induced degradation and an evaluation of the drug–excipient interactions performed for a new-generation bisphosphonate—risedronate
    Gabriela Vlase, Paul Albu, Sorin Cristian Doca, Mădălina Mateescu, Titus Vlase · 2018 · Journal of Thermal Analysis and Calorimetry
  88. Material properties and osteoporosis
    Eleftherios P. Paschalis, Klaus Klaushofer, Markus A. Hartmann · 2019 · F1000Research
  89. Green one-pot synthesis of N-bisphosphonates as antimicrobial and antioxidant agents
    Sreekanth Tellamekala, Mohan Gundluru, Murali Sudileti, Santhisudha Sarva, Chenna Rohini Kumar Putta, C. Suresh Reddy · 2020 · Monatshefte für Chemie - Chemical Monthly
  90. Natural inhibitors from earthworms for the crystallization of calcium oxalate monohydrate
    Xiang Kang, Si Li, Mengya Li, Jiahui Li, Dandan Han, Junbo Gong · 2022 · CrystEngComm
  91. Cyclodextrin-Based Arsenal for Anti-Cancer Treatments
    Hitesh Chopra, Ravinder Verma, Sakshi Kaushik, Jatin Parashar, Kumud Madan, Afsareen Bano, Rashmi Bhardwaj, Parijat Pandey, Beena Kumari, Deepika Purohit et al. · 2022 · Critical Reviews in Therapeutic Drug Carrier Systems
  92. Preventing septic implant failures in osteoporotic hip fractures using antibiotic-loaded functionalized nanocement
    Aman Nikhil, Irfan Qayoom, Ankita Das, Ashok Kumar · 2024 · Chemical Engineering Journal
  93. Zoledrinic Acid Induces Steoblastic Differentiation of Mesenchymal Stem Cells without Change in Hypomethylation Status of OSTERIX Promoter.
    Majid Farshdousti Hagh, Mehrdad Noruzinia, Yousef Mortazavi, Masoud Soleimani, Saeid Kaviani, Maryam Mahmoodinia Maymand · 2012 · PubMed Central
  94. Controlled surface‐initiated ring‐opening polymerization of L ‐lactide from risedronate‐anchored hydroxyapatite nanocrystals: Novel synthesis of biodegradable hydroxyapatite/poly( L ‐lactide) nanocomposites
    Jie Chen, Wei Chen, Chao Deng, Fenghua Meng, Zhiyuan Zhong · 2011 · Journal of Polymer Science Part A Polymer Chemistry
  95. An update on the pharmacology of bisphosphonates and analogues with lower bone affinity
    Fraser P. Coxon · 2008 · IBMS BoneKEy
  96. Exploiting the anticancer effects of a nitrogen bisphosphonate nanomedicine for glioblastoma multiforme
    Lynn Jena, Lindsey A. Bennie, Emma M. McErlean, Sreekanth Pentlavalli, Kim Glass, James F. Burrows, Victoria L. Kett, Niamh E. Buckley, Jonathan A. Coulter, Nicholas Dunne et al. · 2021 · Journal of Nanobiotechnology
  97. A brief review and clinical evidences of teriparatide therapy for atypical femoral fractures associated with long-term bisphosphonate treatment
    Jianpeng Gao, Xiao Liu, Xiaoyong Wu, Xiaoya Li, Jianheng Liu, Ming Li · 2023 · Frontiers in Surgery
  98. Dynamic Analyses of the Short‐Term Effects of Different Bisphosphonates Using Intravital Two‐Photon Microscopy
    Junichi Kikuta, Mai Shirazaki, Takao Sudo, Hiroki Mizuno, Akito Morimoto, Riko Suehara, Masafumi Minoshima, Kazuya Kikuchi, Masaru Ishii · 2018 · JBMR Plus
  99. Basic Aspects of Bone Mineralization
    Paul Roschger, Barbara M. Misof, Klaus Klaushofer A · 2020 · Contemporary Endocrinology
  100. Effect of oral zoledronate administration on bone turnover in older women
    Ian R. Reid, Jingyuan Wen, Anna Mellar, Mengyang Liu, Amani Jabr, Anne M. Horne · 2022 · British Journal of Clinical Pharmacology